Evidence map›Paper›PMID 34016912›Full record

ArticleJournal of occupational and environmental medicine2021

Proposed Framework for Considering SARS-CoV-2 Antigen Testing of Unexposed Asymptomatic Workers in Selected Workplaces.

Paul A Schulte, John D Piacentino, David N Weissman, Marie A de Perio, Sophia K Chiu, Lewis J Radonovich, Douglas Trout, Don Beezhold, Frank J Hearl, John Howard

Open access · greenAbstract read
In one paragraph

Article in Journal of occupational and environmental medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. COVID-19 Rapid Antigen Tests: Bibliometric Analysis of the Scientific Literature.International journal of environmental research and public health · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Paul A SchulteNational Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, Ohio (Dr Schulte); National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Washington, DC (Dr Piacentino, Mr Hearl, and Dr Howard); National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia (Dr Weissman and Dr Radonovich); National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, Ohio (Dr de Perio, Dr Chiu, and Dr Trout); National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia (Dr Beezhold).
John D Piacentino
David N Weissman
Marie A de Perio
Sophia K Chiu
Lewis J Radonovich
Douglas Trout
Don Beezhold
Frank J Hearl
John Howard
Trout Unlimited · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo propose a framework for considering SARS-CoV-2 antigen testing of unexposed asymptomatic workers in selected workplaces.

methodsThis is a commentary based on established occupational safety and health principles, published articles, and other pertinent literature, including non-peer-reviewed preprints in medrixiv.org prior to April 16, 2021.

resultsNot applicable to this commentary/viewpoint article.

conclusionAntigen testing is a rapidly evolving and useful public health tool that can be used to guide measures to reduce spread of SARS-CoV-2 in the community and in selected workplaces. This commentary provides a proposed framework for occupational safety and health practitioners and employers for considering antigen testing as a method to screen asymptomatic workers in selected non-healthcare settings. When applied selectively, antigen testing can be a useful, effective part of a comprehensive workplace program for COVID-19 prevention and control.

Indexed as

COVID-19Occupational HealthCOVID-19 Serological TestingHumansSARS-CoV-2Workplace

Identifiers

PMID34016912
PMCPMC8327768
OpenAlexW3162578065

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.